Vaccina Versus HIV Could Reach Two Years

Tests of three different vaccines are close to entering their final stages, causing experts to be future optimists, Kosovo Preress broadcasts.

The results of vaccine experiments known as HVTN 702, Imbokodo and Mosaico ) will be available as early as next year.

People with HIV can take drugs that make their viral load unreadable, which means they cannot transmit it, even through sex.

However, a vaccine currently does not exist to protect against being affected by the virus, which is carried by 37 million people worldwide.

The head of two tests, Susan Buchbinder, director of Brigde HIV's research program at the Department of Public Health in San Francisco, says that '%ky is probably one of the most optimistic moments we've been in.

“Even a partially effective vaccine would be “an extraordinary progress” and the true “would have the power to change the epidemic trajector””, she said.

Two vaccines consist of six injections, with slightly different types administered during the last two visits to the clinic.

HIV progressively damages crucial cells in the immune system, which weakens the body's ability to fight infections.

If not treated, this leads to AIDS, the name for a series of deadly infections that the weakened immune system cannot treat.

HIV experts say that a vaccine should be at least 50 percent effective in having game construction in fighting the number of cases.

Doctors can already drop profile before exposure ( PrEP, a daily pill that very high-risk people can get to prevent access to HIV.

And those with HIV can receive anti-retroviral therapy (ART), which ensure that they have an unintelligible viral load, which means the amount of the virus in their blood is low.

Results from Imbokodo vaccine are expected in 2021, while those from Mosaiko are expected in 2023